| Invasive meningococcal disease in Quebec, Canada, due to an emerging clone of ST-269 serogroup B meningococci with serotype antigen 17 and serosubtype antigen P1. 19 (B: 17: P1 … DKS Law, M Lorange, L Ringuette, R Dion, M Giguere, AM Henderson, ... Journal of Clinical Microbiology 44 (8), 2743-2749, 2006 | 64 | 2006 |
| First documented outbreak of Listeria monocytogenes in Quebec, 2002 C Gaulin, D Ramsay, L Ringuette, J Ismail Canada communicable disease report= Relevé des maladies transmissibles au …, 2003 | 52 | 2003 |
| Surveillance of Invasive Streptococcus pneumoniaeInfection in the Province of Quebec, Canada, from 1996 to 1998: Serotype Distribution, Antimicrobial … LP Jette, G Delage, L Ringuette, R Allard, P De Wals, F Lamothe, V Loo, ... Journal of clinical microbiology 39 (2), 733-737, 2001 | 49 | 2001 |
| Meningococcal infections in the province of Quebec, Canada, during the period 1991 to 1992 L Ringuette, M Lorange, A Ryan, F Ashton Journal of Clinical Microbiology 33 (1), 53-57, 1995 | 45 | 1995 |
| Comparison of Disk Diffusion and Agar Dilution Methods for Erythromycin and Ciprofloxacin Susceptibility Testing of Campylobacter jejuni subsp. jejuni C Gaudreau, Y Girouard, L Ringuette, C Tsimiklis Antimicrobial agents and chemotherapy 51 (4), 1524-1526, 2007 | 39 | 2007 |
| Evaluation of three glutaraldehyde-based disinfectants used in endoscopy LP Jette, L Ringuette, M Ishak, M Miller, P Saint-Antoine Journal of Hospital Infection 30 (4), 295-303, 1995 | 34 | 1995 |
| Phenotypic and genetic characterization of a unique variant of serogroup C ET-15 meningococci (with the antigenic formula C: 2a: P1. 7, 1) causing invasive meningococcal … RSW Tsang, CM Tsai, P Zhu, L Ringuette, M Lorange, DKS Law Journal of clinical microbiology 42 (4), 1460-1465, 2004 | 26 | 2004 |
| Pneumococcal resistance to antimicrobial agents in the province of Quebec, Canada LP Jette, L Ringuette, A Dascal, JR Lapointe, P Turgeon Journal of clinical microbiology 32 (10), 2572-2575, 1994 | 23 | 1994 |
| Ethics education in public health: where are we now and where are we going? V Doudenkova, JC Bélisle-Pipon, L Ringuette, V Ravitsky, ... International Journal of Ethics Education 2 (2), 109-124, 2017 | 11 | 2017 |
| Conflicts of interest and the (in) dependence of experts advising government on immunization policies JC Bélisle-Pipon, L Ringuette, AI Cloutier, V Doudenkova, ... Vaccine 36 (49), 7439-7444, 2018 | 10 | 2018 |
| Molecular characterization of four Haemophilus influenzae serotype a strains isolated from patients in Quebec, Canada ML Sill, J Zhou, DKS Law, M Lorange, L Ringuette, S Bekal, RSW Tsang Canadian journal of microbiology 53 (10), 1191-1194, 2007 | 10 | 2007 |
| Emergence of Neisseria gonorrhoeae strains with decreased susceptibility to ciprofloxacin--Quebec, 1994-1995 L Ringuette, T Trudeau, P Turcotte, K Yeung, R Remis, L Perron, ... Canada communicable disease report= Releve des maladies transmissibles au …, 1996 | 9 | 1996 |
| Protecting public health or commercial interests? The importance of transparency during immunization campaigns JC Bélisle-Pipon, L Ringuette, V Doudenkova, B Williams-Jones Ethics, Medicine and Public Health 3 (2), 241-245, 2017 | 8 | 2017 |
| Invasive meningococcal disease in Quebec DKS Law, M Lorange, L Ringuette, R Dion, M Giguere, AM Henderson, ... Canada, due to an emerging clone of ST-269 serogroup B meningococci with …, 0 | 8 | |
| Experts sous influence? Quand la non-divulgation des conflits d’intérêts met à risque la confiance du public B Williams-Jones, JC Bélisle-Pipon, R Louise, C Anne-Isabelle, D Victoria Autour de l’intégrité scientifique, la loyauté, et la probité: aspects …, 2016 | 5 | 2016 |
| Expert advisory committees & conflict of interest JC Bélisle-Pipon, L Ringuette, B Williams-Jones Impact Ethics, 2017 | 3 | 2017 |
| Améliorer la compréhension et la gestion des conflits d’intérêts des experts conseillant la prise de décisions en santé publique AI Cloutier, JC Bélisle-Pipon, L Ringuette, V Doudenkova, ... BioéthiqueOnline 5, 2016 | 3 | 2016 |
| Streptococcus pneumoniae with reduced susceptibility to penicillin G--Quebec L Jette, L Ringuette Canada communicable disease report= Releve des maladies transmissibles au …, 1994 | 2 | 1994 |
| How to navigate the application of ethics norms in global health research: reflections based on qualitative research conducted with people with disabilities in Uganda M Mac-Seing, L Ringuette, K Zinszer, B Godard, C Zarowsky BMC Medical Ethics 22 (1), 1-7, 2021 | 1 | 2021 |
| Neisseria meningitidis with reduced susceptibility to penicillin isolated from blood culture--Quebec L Ringuette, LP Jetté, K Pouliot Canada communicable disease report= Releve des maladies transmissibles au …, 1993 | 1 | 1993 |
